News

Recession Has Curbed Growth of Health Costs Somewhat


 

WASHINGTON — Even as the economic downturn causes private health spending to slow, public sector health spending is rising, according to a federal analysis.

An estimated 3.4 million people may lose private health insurance coverage in 2009 and another 2.6 million may lose coverage in 2010, said Sean Keehan, an actuary at the Centers for Medicare and Medicaid Services' Office of the Actuary.

Total U.S. health care spending was an estimated $2.4 trillion in 2008—an increase of 6.1% over 2007, according to the annual projection of health spending trends published online in the journal Health Affairs. This year, spending is expected to grow by only 5.5%.

That rate of growth is expected to far outpace the nation's gross domestic product in 2009. Economists for the CMS said they predict the GDP to shrink by 0.2% this year. Meanwhile, the health care share of GDP is expected to grow 1.4%—the biggest annual jump as a portion of GDP since economists first started tracking this indicator in 1960, said Christopher Truffer, a CMS actuary. Health spending will account for 17.6% of the GDP in 2009, according to the report (Health Affairs 2009 Feb. 24 [doi:10.1377/hlthaff.28.2.w346

Absent any policy changes, health care is on track to gobble up one-fifth of the nation's dollar by 2018, Mr. Truffer and his colleagues said.

The economists projected that overall health spending will rise by only 4.6% in 2010, thanks largely to the mandated 21% reduction in physician payments required under the Sustainable Growth Rate target set by Medicare.

However, since Congress usually eliminates the cuts or grants a fee increase every year, the CMS economists calculated some alternative scenarios. If payments were kept constant, Medicare spending would rise 6.4%, or 3.9% faster than if the cuts went into effect. Overall national health spending would rise 5.4%, or 0.8% more.

Medicaid spending will grow 9.6% in 2009, up from 6.9% in 2008. Private health insurance benefits spending grew an estimated 5.8% in 2008, but will rise only 4.1% in 2009.

The CMS projections make it seem like cost-containment efforts are having a negligible effect on restraining overall health spending. The economists said the Medicare fee cuts would make a difference, but that they did not have the data to calculate whether other cost-containment efforts in the private sector in particular were having any effect on restraining health spending.

However, prescription drug spending has dropped as a result of insurers successfully driving an increase in the utilization of generic drugs, said John Poisal, deputy director of the Office of the Actuary. Overall, the public and private sector spent 3.5% more on drugs in 2008, compared with a 4.9% increase the previous year. Overall, the nation spent $235 billion on prescriptions in 2008. The analysts expected a 4% rise in 2009.

Hospital spending is expected to grow only 5.7% in 2009, compared with a 7.2% increase in 2008, as cash-strapped Americans put off elective procedures and as insurers continue to clamp down, the actuaries said.

The analysts projected spending trends to 2018, but said that their assumptions would change if the recession continued beyond early 2010 or if any significant health care reform occurs.

CMS Chief Actuary Rick Foster said that he did not expect to see significant health reform proposals in the budget, however. “I don't believe the administration is yet in the position to announce specifics or build a detailed plan,” he said. “I do expect there to be a discussion of the general idea or general thoughts” about health reform, he added.

Recommended Reading

ICD-10 Transition Deadline Is Oct. 1, 2013
MDedge Rheumatology
2009 Physician Quality Reporting Measures Now Available Online
MDedge Rheumatology
Policy & Practice
MDedge Rheumatology
Health Reform Figures Large in Budget
MDedge Rheumatology
SCHIP Aids Access; Ped Rheum Care Hard to Find
MDedge Rheumatology
Retail Health Care Clinics Still Poised for Growth
MDedge Rheumatology
Impact of Stem Cell Reversal 'Limited' in Rheum
MDedge Rheumatology
HIT Incentives in Stimulus Package Causing Controversy
MDedge Rheumatology
Policy & Practice
MDedge Rheumatology
Medical School Deans Tackle Access, Cost Issues
MDedge Rheumatology